|
HMG20A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.205700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.128200E-01 |
| Normal-vs-Stage2 |
3.815400E-01 |
| Normal-vs-Stage3 |
3.297600E-03 |
| Normal-vs-Stage4 |
1.738780E-03 |
| Stage1-vs-Stage2 |
3.834200E-01 |
| Stage1-vs-Stage3 |
2.016400E-03 |
| Stage1-vs-Stage4 |
1.424660E-03 |
| Stage2-vs-Stage3 |
1.886420E-01 |
| Stage2-vs-Stage4 |
1.096420E-01 |
| Stage3-vs-Stage4 |
6.272000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.976500E-02 |
| Normal-vs-AfricanAmerican |
1.430990E-01 |
| Normal-vs-Asian |
5.727800E-01 |
| Caucasian-vs-AfricanAmerican |
5.125000E-01 |
| Caucasian-vs-Asian |
2.005800E-01 |
| AfricanAmerican-vs-Asian |
2.255400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.374500E-02 |
| Normal-vs-Female |
3.208600E-01 |
| Male-vs-Female |
2.647000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.327800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.289000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.223790E-02 |
| Normal-vs-Age(81-100Yrs) |
1.182020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.131600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.509600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.455200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.311600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.367450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.218400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.520700E-03 |
| Normal-vs-Grade 2 |
9.947200E-01 |
| Normal-vs-Grade 3 |
6.043400E-03 |
| Normal-vs-Grade 4 |
5.759900E-04 |
| Grade 1-vs-Grade 2 |
3.734100E-02 |
| Grade 1-vs-Grade 3 |
6.234000E-04 |
| Grade 1-vs-Grade 4 |
2.037000E-04 |
| Grade 2-vs-Grade 3 |
2.400200E-03 |
| Grade 2-vs-Grade 4 |
3.951800E-04 |
| Grade 3-vs-Grade 4 |
1.193390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.854400E-01 |
| Normal-vs-ccB subtype |
2.423800E-02 |
| ccA subtype-vs-ccB subtype |
1.103060E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.360810E-01 |
| Normal-vs-N1 |
3.451400E-01 |
| N0-vs-N1 |
5.493000E-01 |
|
|
